In this brief report, we demonstrate that the Cav3.3 T-type voltage-gated calcium channel subtype is involved in our FRICT-ION model of chronic trigeminal neuropathic pain. We first showed that the Cacna1i gene encoding Cav3.3 is significantly upregulated in whole trigeminal ganglia of FRICT-ION mice compared to controls at week 10 post-injury. We confirmed protein upregulation of Cav3.3 compared to controls using Western blot analysis of whole trigeminal ganglia tissues. Finally, we demonstrated that intraperitoneal injection of a selective TAT-based Cav3.3 blocking peptide in FRICT-ION mice significantly reduces Cav3.3 protein expression at the peak anti-allodynic effect (4 hrs post-injection) of the attenuated neuropathic pain behavior. We also suggest that blockade of Cav3.3 may be more effective in attenuating trigeminal neuropathic pain in female than male FRICT-ION mice. Therefore, blocking or attenuating Cav3.3 function may be an effective strategy for the treatment of trigeminal neuropathic pain.

Department of Anesthesiology and Critical Care Medicine University of New Mexico School of Medicine Albuquerque NM USA

Institute of Biology and Medical Genetics 1st Faculty of Medicine Charles University Prague Czech Republic

Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences Prague Czech Republic

Zobrazit více v PubMed

Montera M, Westlund K.. Minimally invasive oral surgery induction of the FRICT-ION chronic neuropathic pain model. BIO-Protoc [Internet]. 2020. [cited 2020 April20];10. Available from: https://bio-protocol.org/e3591 PubMed PMC

Gewandter JS, Dworkin RH, Turk DC, et al. Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations. Pain. 2015;156:1184–1197. PubMed PMC

Cooper SA, Desjardins PJ. The value of the dental impaction pain model in drug development. Methods Mol Biol Clifton NJ. 2010;617:175–190. PubMed

Zhang M, Hu M, Montera MA, et al. Sustained relief of trigeminal neuropathic pain by a blood–brain barrier penetrable PPAR gamma agonist. Mol Pain [Internet]. 2019. [cited 2020 October26];15:174480691988449. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843736/ PubMed PMC

Ma F, Zhang L, Lyons D, et al. Orofacial neuropathic pain mouse model induced by trigeminal inflammatory compression (TIC) of the infraorbital nerve. Mol Brain. 2012;5:44. PubMed PMC

Bangash MA, Alles SRA, Santana-Varela S, et al. Distinct transcriptional responses of mouse sensory neurons in models of human chronic pain conditions. Wellcome Open Res [Internet]. 2018. [cited 2020 October9];3:78. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053702/ PubMed PMC

Buonvicino D, Urru M, Muzzi M, et al. Trigeminal ganglion transcriptome analysis in 2 rat models of medication-overuse headache reveals coherent and widespread induction of pronociceptive gene expression patterns. Pain. 2018;159:1980–1988. PubMed

Danaher RJ, Zhang L, Donley CJ, et al. Histone deacetylase inhibitors prevent persistent hypersensitivity in an orofacial neuropathic pain model. Mol Pain [Internet]. 2018. [cited 2019 August23];14:174480691879676. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124181/ PubMed PMC

Cmarko L, Weiss N. Selective inhibition of neuronal Cav3.3 T-type calcium channels by TAT-based channel peptide. Mol Brain. 2020;13:95. PubMed PMC

Greenbaum D, Colangelo C, Williams K, et al. Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol. 2003;4:117. PubMed PMC

Talley EM, Cribbs LL, Lee J-H, et al. Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels. J Neurosci. 1999;19:1895–1911. PubMed PMC

Snutch TP, Zamponi GW. Recent advances in the development of T-type calcium channel blockers for pain intervention. Br J Pharmacol. 2018;175:2375–2383. PubMed PMC

Zamponi GW. Targeting voltage-gated calcium channels in neurological and psychiatric diseases. Nat Rev Drug Discov. 2016;15:19–34. PubMed

Gadotti VM, Caballero AG, Berger ND, et al. Small organic molecule disruptors of Cav3.2 - USP5 interactions reverse inflammatory and neuropathic pain. Mol Pain. 2015;11:12. PubMed PMC

García-Caballero A, Gadotti VM, Stemkowski P, et al. The deubiquitinating enzyme USP5 modulates neuropathic and inflammatory pain by enhancing Cav3.2 channel activity. Neuron. 2014;83:1144–1158. PubMed

Gomez K, Calderón-Rivera A, Sandoval A, et al. Cdk5-dependent phosphorylation of CaV3.2 T-type channels: possible role in nerve ligation-induced neuropathic allodynia and the compound action potential in primary afferent C fibers. J Neurosci Off J Soc Neurosci. 2020;40:283–296. PubMed PMC

Shen F-Y, Chen Z-Y, Zhong W, et al. Alleviation of neuropathic pain by regulating T-type calcium channels in rat anterior cingulate cortex. Mol Pain. 2015;11:7. PubMed PMC

Shin SM, Cai Y, Itson-Zoske B, et al. Enhanced T-type calcium channel 3.2 activity in sensory neurons contributes to neuropathic-like pain of monosodium iodoacetate-induced knee osteoarthritis. Mol Pain. 2020;16:1744806920963807. PubMed PMC

Kerckhove N, Pereira B, Soriot-Thomas S, et al. Efficacy and safety of a T-type calcium channel blocker in patients with neuropathic pain: A proof-of-concept, randomized, double-blind and controlled trial. Eur J Pain Lond Engl. 2018;22:1321–1330. PubMed

Wen X, Li Z, Chen Z, et al. Intrathecal administration of Cav3.2 and Cav3.3 antisense oligonucleotide reverses tactile allodynia and thermal hyperalgesia in rats following chronic compression of dorsal root of ganglion. Acta Pharmacol Sin. 2006;27:1547–1552. PubMed

Choi S, Yu E, Hwang E, et al. Pathophysiological implication of CaV3.1 T-type Ca2+ channels in trigeminal neuropathic pain. Proc Natl Acad Sci U S A. 2016;113:2270–2275. PubMed PMC

Bauer CS, Rahman W, Tran-van-Minh A, et al. The anti-allodynic alpha(2)delta ligand pregabalin inhibits the trafficking of the calcium channel alpha(2)delta-1 subunit to presynaptic terminals in vivo. Biochem Soc Trans. 2010;38:525–528. PubMed

Bauer CS, Nieto-Rostro M, Rahman W, et al. The increased trafficking of the calcium channel subunit alpha2delta-1 to presynaptic terminals in neuropathic pain is inhibited by the alpha2delta ligand pregabalin. J Neurosci. 2009;29:4076–4088. PubMed PMC

Electrophysiological and computational analysis of Cav3.2 channel variants associated with familial trigeminal neuralgia